Table 3.

Comparison of serum levels of IL-10 and GFAP among glioma patients with different clinicopathological features

Parameters		Cases	IL-10 (ng/L)	t/χ2 value	P value	GFAP (ng/L)	t/χ2 value	P value
Gender	Male	39	171.45±36.28	1.417	0.159	59.14±12.05	1.133	0.260
	Female	36	181.41±38.71			67.72±14.64
Age	≤60 years old	41	172.63±27.28	0.850	0.397	57.28±10.92	0.827	0.410
	>60 years old	34	180.57±30.15			70.47±11.83
Location	Loubus fromatis	41	170.73±39.06	0.551	0.583	59.06±11.04	1.102	0.273
	Temporal lobe	21	171.93±28.07			57.14±10.85
	Parietal lobe	7	171.71±27.94			58.29±11.73
	Others	6	183.26±34.21			66.37±13.29
Tumor diameter	≤3 cm	11	170.38±21.74	1.378	0.171	57.87±9.87	1.111	0.269
	3-5 cm	35	175.22±23.58			59.23±11.26
	>5 cm	29	181.47±26.39			65.31±13.85
KPS scores	<70 points	38	175.57±24.67	0.837	0.405	61.26±12.24	0.845	0.399
	≥70 points	37	177.21±26.35			65.38±13.73
WHO Class	I and II grading	37	163.86±19.27	3.550	<0.001	71.69±13.95	6.064	<0.001
	III and IV grading	38	188.63±37.94			54.83±9.69
Genotype of P53	wild type	44	157.19±26.38	6.034	<0.001	73.95±16.17	6.050	<0.001
	Mutant type	31	203.25±39.76			55.73±9.88
Ki-67 expression	Low	42	165.17±20.94	3.491	<0.001	69.65±12.18	4.126	<0.001
	High	33	190.25±40.17			58.19±11.75

Note: IL-10: Interleukin-10; GFPA: Glial fibrillary acidic protein; KPS: Karnofsky Performance Scale; WHO: World Health Organization; P53: Protein 53.